EUCTR2019-000757-31-NO进行中（未招募）1 期
Effect of zoledronic acid on osteoarthritis of the hip
South-east health region of Noway0 个研究点目标入组 70 人开始时间: 2019年2月14日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Hip Osteoarthritis. Bone marrow lesion > 1 cm. Age 50-80. pain VAS >4
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 35
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 35
排除标准
- •kidney failure GFR <35. Age <50 or >80. Prosthesis on contralateral hip or ipsilateral knee. calcium or vitamin d deficiency. Use of other bone modulating medication
研究者
相似试验
进行中（未招募）
1 期
Zoledronic acid in patients with metastatic prostate cancer treated with abiraterone acetate: impact on bone mineral densityMetastatic castration-resistant prostate cancerMedDRA version: 18.0Level: PTClassification code 10036909Term: Prostate cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2013-001146-34-FRCentre Oscar Lambret
招募中
4 期
Effect of Zoledronic Acid in Primary Knee OsteoarthritisPrimary OsteoarthritisNCT06051344Toufiqe-E-Ealahi92
已完成
2 期
Zoledronic acid as Disease-modifying drug in Knee osteoarthritis (ZODIAK)NL-OMON24160niversity Medical Center Utrecht86
已完成
2 期
ZOledronic acid as DIseAse-modifying drug in Knee osteoarthritis (ZODIAK)10023213osteoarthritisNL-OMON50547niversitair Medisch Centrum Utrecht86
尚未招募
不适用
Effect of Zoledronic Acid Treatment on Bone-related Events in Breast Cancer Patients With Bone Metastases: a Prospective, Multicenter, Real-world StudyHistologically Confirmed Breast Cancer ,Diagnosis of Bone MetastasisNCT05480189Zhejiang Cancer Hospital1,000